Kapitalo Investimentos’s Zymeworks ZYME Stock Holding History

Kapitalo Investimentos’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-16,449	Closed	-$149K	–	728
2023 Q1	$149K	Buy	+16,449	New	+$143K	0.05%	220

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Kapitalo Investimentos's ZYME Position: Q2 2023 in Review

Kapitalo Investimentos sold out of Zymeworks (ZYME) in Q2 2023, closing a stake of 16,449 shares — an estimated $149K sold.

Kapitalo Investimentos first reported a position in ZYME in Q1 2023 and held it in 1 quarter. The position peaked at $149K in Q1 2023. 137 funds tracked by Wall St. Rank hold ZYME as of Q2 2023.

Kapitalo Investimentos reported no remaining Zymeworks position as of Q2 2023 after selling out during the quarter.
Kapitalo Investimentos sold 16,449 Zymeworks shares in Q2 2023, an estimated $149K.
Kapitalo Investimentos first reported a position in Zymeworks in Q1 2023 and held it in 1 quarter.
Kapitalo Investimentos's Zymeworks position peaked at $149K in Q1 2023.
137 funds tracked by Wall St. Rank held Zymeworks as of Q2 2023.

Based on Kapitalo Investimentos's 13F filing for Q2 2023, filed 29 Mar 2024.